Condition
Highly Sensitized Patients Awaiting Kidney Transplant clinical trials and research
As of November 12, 2026, Find a Trial lists 2 Highly Sensitized Patients Awaiting Kidney Transplant clinical trials that are recruiting, at sites in 2 countries (most in Spain (1), China (1)). By phase: Phase 1/2 (1), Early Phase 1 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2Clinical trials
- 2Countries
All recruiting trials (2)
-
Immune Reset to Enable Kidney Transplant for Highly Sensitized Patients
This study tests whether a temporary immune system reboot using a patient’s own stem cells can help highly sensitized kidney patients receive a compatible transplant.
-
CAR-T therapy targeting CD19 and BCMA to desensitize highly sensitized kidney transplant candidates
This will test whether AZD0120, a dual CD19/BCMA CAR-T cell therapy, can safely reduce donor-specific antibodies and enable kidney transplant in highly sensitized adults with end-stage kidney disease.
Related topics
Quick answers
How many Highly Sensitized Patients Awaiting Kidney Transplant clinical trials are recruiting right now?
2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 2 countries. The most sites are in Spain (1 trial), China (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 1/2: 1, Early Phase 1: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.